John Bernard

6 papers receiving 532 citations

John Bernard's Hit Papers

Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial—FIRSTANA 2017 · 287 citations
2870+3+6Years since publication50100150200250

Peers

John Bernard
Comparison fields: 5 of 46
  • Pulmonary and Respiratory Medicine 386
  • Drug Discovery 1
  • Oncology 75
  • Geriatrics and Gerontology 7
  • Biomaterials 16
Replace Uwe Keppler with:
Uwe Keppler Germany
Assaad Chemaissani Germany
Tracy Varrieur United States
Laura Sierra United States
Tsuyoshi Shirakawa Japan
Aldo Iop Italy
Brian Anthony DiCarlo United States
Catherine M. Ash United Kingdom
Puey Ling Chia Australia
Samer S. Kasbari United States
John Bernard relative to Uwe Keppler Germany Uwe Keppler's profile →
Citations per field
00.5×10×20×34.5×
Uwe Keppler · 1×
Citations per year

Countries citing papers authored by John Bernard

Since Specialization
Citations

This map shows the geographic impact of John Bernard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Bernard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Bernard more than expected).

Fields of papers citing papers by John Bernard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Bernard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Bernard. The network helps show where John Bernard may publish in the future.

Co-authors

The 25 scholars most cited alongside John Bernard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Bernard Line = papers co-authored together John Bernard links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1
Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial—FIRSTANA
Hit paper breakdown →
2017287
2 2017210
3 202026
4 201812
5 20247
6 20162

About John Bernard

John Bernard is a scholar working on Pulmonary and Respiratory Medicine, Genetics, Hematology, Endocrinology, Diabetes and Metabolism and Nuclear Energy and Engineering, having authored 6 papers that have together received 544 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (3 papers), Glioma Diagnosis and Treatment (1 paper), Hematopoietic Stem Cell Transplantation (1 paper) and Thyroid Cancer Diagnosis and Treatment (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (386 citations), Drug Discovery (1 citation), Oncology (75 citations), Geriatrics and Gerontology (7 citations) and Biomaterials (16 citations). John Bernard has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Mustapha Chadjaa, Daniel Castellano, Orazio Caffo, Oliver A. Sartor, Lisa Sengeløv, Antoine Thiery-Vuillemin, Fred Saad, Marie Hjälm-Eriksson, Steinbjørn Hansen and Liji Shen. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Blood & Cancer, Annals of Oncology, Bone Marrow Transplantation and Endocrine Related Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact